Tata India Pharma and Healthcare Fund
Direct · Growth ₹37.00
17 Jun 2026
NAV
18.1%
3Y CAGR
19.1%
5Y CAGR
13.8%
10Y CAGR
16.5%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
11.86
Sharpe
-19.8%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
NA
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.39 L | 17.0% | -24.2% | 89.8% |
| 3 Years | ₹36.00 L | ₹47.08 L | 19.7% | -2.5% | 41.5% |
| 5 Years | ₹60.00 L | ₹99.68 L | 21.3% | 12.6% | 31.3% |
| 7 Years | ₹84.00 L | ₹1.78 Cr | 20.5% | 11.9% | 27.8% |
| 10 Years | ₹1.20 Cr | ₹3.06 Cr | 17.9% | 16.4% | 19.1% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 17.0% | 14.5% | 13.5% | +2.5% |
| 3 Years | 19.7% | 11.2% | 17.4% | +8.5% |
| 5 Years | 21.3% | 10.4% | 17.1% | +10.9% |
| 7 Years | 20.5% | 10.6% | 16.6% | +9.9% |
| 10 Years | 17.9% | 11.5% | 16.9% | +6.5% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 16.9% | 8.5% | -17.3% | 76.3% | 0.46 | 1.52 | 70% | — | — |
| 3 Years | 18.1% | 21.3% | -3.4% | 30.5% | 1.28 | 4.23 | 90% | — | — |
| 5 Years | 19.1% | 17.0% | 9.3% | 31.6% | 2.33 | — | 100% | — | — |
| 10 Years | 13.8% | 13.6% | 12.6% | 15.0% | 11.86 | — | 100% | — | — |
-19.8%
Max Drawdown
19 mo
Drawdown Duration
13 mo
Recovery Time
-6.2%
Avg Drawdown
Calmar Ratio by Duration
0.85
1Y
0.91
3Y
0.96
5Y
0.90
7Y
0.70
10Y
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +6.86 | 0.60 | 64.7% | 53.8% | 7.6% | -3.1% |
| 3 Years | +14.93 | 0.59 | 72.1% | 50.5% | 22.7% | 8.7% |
| 5 Years | +7.25 | 0.56 | 60.9% | 48.8% | 15.1% | 8.9% |
| 7 Years | +13.56 | 0.52 | 58.9% | 42.2% | 22.3% | 10.9% |
| 10 Years | +5.81 | 0.54 | 60.8% | 51.0% | 15.0% | 11.4% |
| 12 Years | +3.22 | 0.55 | 60.4% | 52.3% | 11.5% | 9.7% |
| 15 Years | +1.92 | 0.55 | 60.4% | 52.3% | 9.1% | 7.7% |
38
Total Holdings
53.3%
Top 10 Weight
5
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LTD | 9.38% |
| 2 | HEALTHCARE GLOBAL ENTERPRISES LTD | 5.87% |
| 3 | DIVI LABORATORIES LTD | 5.80% |
| 4 | ABBOTT INDIA LTD | 5.41% |
| 5 | CIPLA LTD | 5.18% |
| 6 | MAX HEALTHCARE INSTITUTE LTD | 4.80% |
| 7 | APOLLO HOSPITALS ENTERPRISE LTD | 4.56% |
| 8 | RAINBOW CHILDRENS MEDICARE LTD | 4.52% |
| 9 | DR REDDYS LABORATORIES LTD | 4.02% |
| 10 | MANKIND PHARMA LTD | 3.77% |